This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Remegen Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Xuejing Luan
Introduction
Xuejing Luan is a notable inventor based in Shandong, China. He has made significant contributions to the field of medical science, particularly in the development of angiogenesis inhibitors. His work focuses on addressing critical health issues related to retinal diseases.
Latest Patents
Xuejing Luan holds a patent for a bifunctional angiogenesis inhibitor. This innovative invention exhibits both VEGF inhibitory activity and FGF inhibitory activity. It is designed to inhibit cell proliferation, cell migration, and lumen formation induced by dual factors such as VEGF and FGF, as well as high glucose levels. The bifunctional angiogenesis inhibitor is particularly useful in treating conditions like diabetic retinopathy and age-related macular degeneration.
Career Highlights
Luan is currently associated with Remegen Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on treating serious retinal conditions.
Collaborations
Xuejing Luan collaborates with talented individuals in his field, including Xuejing Yao and Ling Wang. These partnerships enhance the innovative capacity of his projects and contribute to the overall success of their research endeavors.
Conclusion
Xuejing Luan's contributions to the field of angiogenesis inhibitors highlight his commitment to advancing medical science. His innovative work has the potential to significantly improve treatment options for retinal diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile